Tetrahydrobiopterin, but Not l -Arginine, Decreases NO Synthase Uncoupling in Cells Expressing High Levels of Endothelial NO Synthase
- 1 January 2006
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 47 (1) , 87-94
- https://doi.org/10.1161/01.hyp.0000196735.85398.0e
Abstract
Endothelial NO synthase (eNOS) produces superoxide when depleted of (6R)-5,6,7,8-tetrahydro-L-biopterin (BH4) and L-arginine by uncoupling the electron flow from NO production. High expression of eNOS has been reported to have beneficial effects in atherosclerotic arteries after relatively short periods of time. However, sustained high expression of eNOS may have disadvantageous vascular effects because of uncoupling. We investigated NO and reactive oxygen species (ROS) production in a microvascular endothelial cell line (bEnd.3) with sustained high eNOS expression and absent inducible NOS and neuronal NOS expression using 4,5-diaminofluorescein diacetate and diacetyldichlorofluorescein as probes, respectively. Unstimulated cells produced both NO and ROS. After stimulation with vascular endothelial growth factor (VEGF), NO and ROS production increased. VEGF-induced ROS production was even further increased by the addition of extra L-arginine. Nomega-nitro-L-arginine methyl ester decreased ROS production. These findings strongly suggest that eNOS is a source of ROS in these cells. Although BH4 levels were increased as compared with another endothelial cell line, eNOS levels were >2 orders of magnitude higher. The addition of BH4 resulted in increased NO production and decreased generation of ROS, indicating that bEnd.3 cells produce ROS through eNOS uncoupling because of relative BH4 deficiency. Nevertheless, eNOS-dependent ROS production was not completely abolished by the addition of BH4, suggesting intrinsic superoxide production by eNOS. This study indicates that potentially beneficial sustained increases in eNOS expression and activity could lead to eNOS uncoupling and superoxide production as a consequence. Therefore, sustained increases of eNOS or VEGF activity should be accompanied by concomitant supplementation of BH4.Keywords
This publication has 31 references indexed in Scilit:
- NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathyAmerican Journal of Physiology-Renal Physiology, 2005
- Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cellsPublished by Oxford University Press (OUP) ,2005
- Nitric oxide donor induces temporal and dose-dependent reduction of gene expression in human endothelial cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Mechanisms of Increased Vascular Superoxide Production in Human Diabetes MellitusCirculation, 2002
- Significance of Nitric Oxide and Peroxynitrite in Permeability Changes of the Retinal Microvascular Endothelial Cell Monolayer Induced by Vascular Endothelial Growth FactorJournal of Vascular Research, 1999
- Superoxide anion and endothelial regulation of arterial toneFree Radical Biology & Medicine, 1996
- Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO productionAtherosclerosis, 1995
- HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell LineJournal of Investigative Dermatology, 1992
- L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.Journal of Clinical Investigation, 1992
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973